title: [Congenital toxoplasmosis following infection occurring late in pregnancy].
abstract: Monthly serological screening of non immune pregnant women is recommended for prevention of congenital toxoplasmosis. However, this screening is often interrupted before delivery. We report a case of congenital toxoplasmosis following infection occurring late in pregnancy. This documented case highlights the need for a final routine serological test, 2-3 weeks post-partum for all seronegative pregnant women. In fact, the screening of congenital toxoplasmosis cases allows the early administration of specific treatment that avoids later severe complications such as chorioretinitis.
authors.affiliation: Service de parasitologie-mycologie, Institut Pasteur de Tunis, Tunis, Tunisie. rym.benabdallah@pasteur.rns.tn
authors.forename: R
authors.initials: R
authors.lastname: Ben Abdallah
authors.forename: E
authors.initials: E
authors.lastname: Siala
authors.forename: R
authors.initials: R
authors.lastname: Maatoug
authors.forename: O
authors.initials: O
authors.lastname: Souissi
authors.forename: K
authors.initials: K
authors.lastname: Aoun
authors.forename: A
authors.initials: A
authors.lastname: Bouratbine
mesh_terms: D000328:Adult; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D002675:Child, Preschool; D004359:Drug Therapy, Combination; D042241:Early Diagnosis; D005260:Female; D006801:Humans; D007223:Infant; D002955:Leucovorin / Q000627:therapeutic use; D008297:Male; D008403:Mass Screening; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000175:diagnosis*; D011739:Pyrimethamine / Q000627:therapeutic use; D013411:Sulfadiazine / Q000627:therapeutic use; D014123:Toxoplasmosis / Q000175:diagnosis* / Q000635:transmission*; D014125:Toxoplasmosis, Congenital / Q000175:diagnosis* / Q000188:drug therapy / Q000635:transmission
chemical_list: D000981:Antiprotozoal Agents; D013411:Sulfadiazine; D002955:Leucovorin; D011739:Pyrimethamine